A Multi-Center Group to Study Acute Liver Failure in Children

Sponsor
University of Pittsburgh (Other)
Overall Status
Completed
CT.gov ID
NCT00986648
Collaborator
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (NIH)
158
20
191
7.9
0

Study Details

Study Description

Brief Summary

The PALF study group began with 20 sites and now continues with 12 sites (11 in the United States and 1 in Canada) in the new funding period. The primary objective of the Pediatric Acute Liver Failure (PALF) study is to collect, maintain, analyze, and report clinical, epidemiological, and outcome data in children with ALF, including information derived from biospecimens.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    The PALF study group will collect clinical, epidemiological and outcome data on children with ALF. This information will be used to develop methods to predict whether a child will recover from the illness without the need for a liver transplant or other life-saving procedure. We believe the methods to predict survival will vary with different patient age groups, but that diagnosis, multi-system organ failure, degree of encephalopathy and level of coagulopathy will be important regardless of patient age. Biological samples, such as blood and liver tissue, will provide opportunities to identify subgroups of patients who have unique treatment requirements and outcomes. In addition, we hope to identify unrecognized mechanisms of liver injury resulting in ALF in children. Eligible study participants will be invited to participate in neurocognitive testing. Since patients that develop acute liver failure experience varying levels of hepatic encephalopathy and cerebral edema, we suspect that there may be residual sub-clinical neurological injury that compromises long-term neurocognitive function. Detailed neurocognitive testing has never been performed in a cohort of children that survive acute liver failure and this study seeks to close that information gap by defining the spectrum of neurocognitive outcomes in this population.

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    158 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    A Multi-Center Group to Study Acute Liver Failure in Children
    Study Start Date :
    Jan 1, 2000
    Actual Primary Completion Date :
    Dec 1, 2015
    Actual Study Completion Date :
    Dec 1, 2015

    Outcome Measures

    Primary Outcome Measures

      Eligibility Criteria

      Criteria

      Ages Eligible for Study:
      N/A to 18 Years
      Sexes Eligible for Study:
      All
      Accepts Healthy Volunteers:
      No
      Inclusion Criteria:
      • Written informed consent/assent

      • Birth through 17 years of age

      • Biochemical evidence of acute liver injury

      • Coagulopathy not corrected by vitamin K (or other intervention intended to correct coagulopathy)

      • The presence of encephalopathy (ENC) is required if the INR is at least 1.5 and less than 2.0

      • If INR is at least 2.0, the presence of ENC is not required

      Exclusion Criteria:
      • Known chronic underlying liver disease

      • Multi-organ system failure following heart surgery or ECMO

      • Solid organ or bone marrow transplantation

      • Acute trauma

      • Previously enrolled in the PALF Cohort Study

      • Other severe illness, condition, or other reason in the opinion of the investigator that would make the patient unsuitable for the study

      Contacts and Locations

      Locations

      Site City State Country Postal Code
      1 University of California, San Francisco San Francisco California United States 94143
      2 Children's Hospital Colorado Aurora Colorado United States 80045
      3 Emory University, Children's Healthcare of Atlanta Atlanta Georgia United States 30322
      4 Ann & Robert H. Lurie Children's Hospital of Chicago Chicago Illinois United States 60611
      5 Riley Children's Hospital Indianapolis Indiana United States 46202
      6 Johns Hopkins University Baltimore Maryland United States 21287
      7 Harvard University, Boston Children's Hospital Boston Massachusetts United States 02115
      8 University of Michigan Ann Arbor Michigan United States 48109
      9 St. Louis Children's Hospital St. Louis Missouri United States 63110
      10 Mount Sinai Hospital New York New York United States 10029
      11 Columbia-Presbyterian New York New York United States 10032
      12 University of Cincinnati, Cincinnati Children's Hospital Cincinnati Ohio United States 45229
      13 Children's Hospital of Philadelphia Philadelphia Pennsylvania United States 19104
      14 Children's Hospital of Pittsburgh of UPMC Pittsburgh Pennsylvania United States 15224
      15 Children's Medical Center of Dallas Dallas Texas United States 75235
      16 Baylor College of Medicine Houston Texas United States 77030
      17 University of Washington Seattle Washington United States 98105
      18 Hospital for Sick Children Toronto Ontario Canada M5G 1X8
      19 Birmingham Children's Hospital Birmingham United Kingdom B4 6NH
      20 King's College Hospital (London, UK) London United Kingdom SE59RS

      Sponsors and Collaborators

      • University of Pittsburgh
      • National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

      Investigators

      • Principal Investigator: Robert H Squires, MD, Children's Hospital of Pittsburgh of UPMC, University of Pittsburgh

      Study Documents (Full-Text)

      None provided.

      More Information

      Publications

      None provided.
      Responsible Party:
      University of Pittsburgh
      ClinicalTrials.gov Identifier:
      NCT00986648
      Other Study ID Numbers:
      • 1U01DK072146-01
      • U01DK072146
      • 2U01DK072146-06
      First Posted:
      Sep 30, 2009
      Last Update Posted:
      Jan 12, 2016
      Last Verified:
      Jan 1, 2016

      Study Results

      No Results Posted as of Jan 12, 2016